Company Filing History:
Years Active: 2009
Title: Andrea C Herréra Gayol: Innovator in Therapeutic Oligonucleotides
Introduction
Andrea C Herréra Gayol is a prominent inventor based in Westmount, Canada. She has made significant contributions to the field of therapeutic oligonucleotides, focusing on innovative solutions for treating diseases. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Andrea holds 1 patent for her invention titled "Therapeutically useful triethyleneglycol cholesteryl oligonucleotides." This patent provides a composition that includes a 5'-OH, 3'-TEG cholesteryl synthetic sequence, specifically SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, and SEQ ID NO:8. The invention outlines methods for using this composition to induce responses in cells, including the inhibition of cellular proliferation, induction of cell cycle arrest, and modulation of extracellular matrix-cell interactions, particularly in cancer and synovial cells.
Career Highlights
Andrea is associated with Bioniche Life Sciences Inc., where she continues to develop her innovative ideas. Her work has been instrumental in advancing therapeutic strategies that target complex diseases.
Collaborations
Throughout her career, Andrea has collaborated with notable colleagues, including Nigel C Phillips and Mario C Filion. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Andrea C Herréra Gayol exemplifies the spirit of innovation in the field of therapeutic oligonucleotides. Her contributions are paving the way for new treatment options and improving the lives of patients facing challenging health conditions.